India's Lincoln Pharma gains most in 15 weeks after quarterly profit jump
BUZZ-India's Lincoln Pharma gains most in 15 weeks after quarterly profit jump ** Shares of pharma products maker Lincoln Pharmaceuticals LINP.NS soar as much as 9.13%, their biggest intraday rise in about 15 weeks, to 646.95 rupees; last up 4%
** Uptick after LINP reports a 30.9% Y/Y rise in consolidated net profit in the June quarter to 362.35 million rupees ($3.80 million); revenue from operations up 15.1% at 1.77 billion rupees
** LINP says it is targeting 10 billion rupees in revenue over the next three years and 15%-18% growth in annual growth rate
** Expects growth to be driven by strong performance in the cardiac, diabetic, dermatology and ENT segments
** Director Munjal Patel says LINP aims to expand its footprint to 90 countries over the next 2-3 years
** LINP shares up 27.6% in 2026
($1 = 95.4250 Indian rupees)
(Reporting by Bharath Rajeswaran in Bengaluru)
((bharath.rajeswaran@thomsonreuters.com; +91 9769003463;))
Recent news on LINCOLN PHARMACEUTICALS
See all newsBrief: Lincoln Pharmaceuticals Sept-Quarter Consol Net Profit 204.3 Million Rupees
India's Lincoln Pharma gains most in 15 weeks after quarterly profit jump
Brief: Lincoln Pharmaceuticals Ltd June-Quarter Consol Net Profit 362.3 Million Rupees
Brief: Lincoln Pharmaceuticals Recommends Dividend Of 1.80 Rupee Per Share For FY2026
Brief: Lincoln Pharmaceuticals Ltd Dec-Quarter Consol Net Profit 286 Million Rupees